Evidence map›Paper›PMID 9250173›Full record

ArticleThe American journal of pathology1997

Presenilin-1 is associated with Alzheimer's disease amyloid.

T Wisniewski, W K Dowjat, B Permanne, J Palha, A Kumar, G Gallo, B Frangione

Abstract read
In one paragraph

Article in The American journal of pathology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Alzheimer's disease and brain development: common molecular pathways.Frontiers in bioscience : a journal and virtual library · 1998
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

T WisniewskiDepartment of Neurology, New York University Medical Center, New York 10016, USA. Thomas.Wisniewski@mcfpo.med.nyu.edu
W K Dowjat
B Permanne
J Palha
A Kumar
G Gallo
B Frangione
New York University · US

Funding

AMYLOIDOSIS AND ALZHEIMERS DISEASER37AG005891 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FRANGIONE, BLAS · 1997 to 2006
$3.3M
AMYLOID ANGIOPATHY, EARLY PLAQUES, AND AGINGR01AG008721 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FRANGIONE, BLAS · 1990 to 2003
$1.8M
AMYLOIDOSIS AND ALZHEIMERS DISEASER01AG005891 · NIA · NEW YORK UNIVERSITY · PI FRANGIONE, BLAS · 1985 to 1995
–
THE BIOCHEMISTRY OF BRAIN AMYLOIDS AND PREAMYLOID LESIONSR35AG010953 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CASTANO, EDUARDO M · 1992 to 1998
–
NIA NIH HHS AG05891NIA NIH HHS AG08721NIA NIH HHS AG10953
6 · The paper itself

Abstract

Mutations in presenilin (PS)-1 and -2, located on chromosome 14 and 1 respectively, are the major association with early-onset familial Alzheimer's disease (FAD). FAD has also been linked to mutations in the amyloid beta precursor protein (beta PP), and the presence of the apolipoprotein E4 allele is a risk factor for late-onset AD. The role of PS in FAD and in sporadic AD is unclear. We previously reported the presence of a PS-1 carboxyl-terminal epitope in neuritic plaques (Wisniewski T, Palha JA, Ghiso J, Frangione B: S182 protein in Alzheimer's disease neuritic plaques. Lancet 1995, 346:1366). In the present study, we examined a number of biochemically different cerebral and systemic amyloidoses, finding the PS-1 carboxy epitope only in association with amyloid beta (A beta) lesions. We confirm the presence of this epitope ultrastructurally in neuritic plaques. In addition, biochemical and amino acid sequence data are presented for an association of the 18-kd carboxy fragment of PS-1 with neuritic plaques with a start at residue 300. Three of the proteins with linkage to AD have now been found as components of neuritic plaques. It remains to be determined whether all of these proteins are involved in the same or different pathological pathway(s) and which of these proteins is the most important for the common, late-onset form of AD.

Indexed as

AdultAgedAlzheimer DiseaseAmyloid beta-PeptidesBlotting, WesternBrainEpitopesHumansImmunohistochemistryMembrane ProteinsMicroscopy, ElectronMiddle AgedPresenilin-1Amyloid beta-PeptidesEpitopesMembrane ProteinsPresenilin-1PSEN1 protein, human

Identifiers

PMID9250173
PMCPMC1858010
OpenAlexW1870239316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.